Annual Meeting

Biochemist chases the role
of retinoids in fat burning

Gelareh Abulwerdi
March 01, 2019

Igor ShmarakovIgor Shmarakov and his mentor published four papers together when their labs were half a world apart.When Igor Shmarakov first learned about retinoids, he had no idea his research interest would send him on a journey back and forth across the globe.

Shmarakov was born and raised in Ukraine. While working on his Ph.D. in biochemistry at Chernivtsi National University, he studied the role of retinoids, natural and synthetic derivatives of retinol, or vitamin A, in inhibiting tumor growth in rat models. After earning his degree, he was appointed an associate professor in the university’s department of biochemistry and biotechnology.

In 2008, Shmarakov received a one-year Fulbright scholarship to do a collaborative research study and was matched with William S. Blaner, a professor of nutritional medicine at the Columbia University College of Physicians and Surgeons, thus beginning a fruitful academic relationship.

Shmarakov returned to Ukraine when his fellowship ended, but he was determined to come back to the U.S. to pursue his dream of becoming an independent researcher. He had a lab at Chernivtsi and supervised graduate students, Shmarakov said, “but at the same time, I continued doing collaborative research studies with Dr. Blaner.”

The long-distance partnership was a challenge, but the two published four papers together between 2009 and 2016. In 2016, Shmarakov applied for an associate research scientist position at Columbia, where he now works under Blaner’s mentorship.

“(The) transition from the Ukrainian academic system into the American academic system was the biggest challenge for me,” Shmarakov said. “Dr. Blaner was very supportive. I owe him. … He kept me scientifically active, and that’s how I was able to come back to the U.S.”

The Journal of Lipid Research has invited Shmarakov to talk about his work in the field of metabolic disease at the 2019 American Society for Biochemistry and Molecular Biology annual meeting.

Role of RBP4 in metabolic disorders

Nonalcoholic fatty liver disease is a metabolic disorder caused by accumulation of fat in the liver. Scientists originally thought the sole function of retinol binding protein 4, or RBP4, was to transport retinol to extrahepatic tissues in times of dietary insufficiency. It is now proposed that adipose-derived RBP4 contributes to the pathogenesis of type 2 diabetes, linking type 2 diabetes with obesity and other obesity-related metabolic diseases.

RBP4 is expressed in both white and brown adipose tissue. The latter, called BAT, contains a large number of mitochondrial uncoupling proteins, allowing them to dissipate thermal energy rather than synthesize ATP. Therefore, metabolically active BAT has therapeutic potential in metabolic disorders.

To study the role of adipocyte-derived RBP4 in metabolic disease, Igor Shmarakov uses several transgenic mouse models, including one that overexpresses human RBP4 in both white and brown adipocytes. When fed a high-fat diet, these adi-hRBP4 mice develop nonalcoholic fatty liver disease, obesity and insulin resistance more readily than matched wild-type mice. Shmarakov’s recent work explores the biochemical cause of this higher weight gain in the adi-hRBP4 mice. The further increase in RBP4 expression in the adi-hRBP4 mice involves a decrease in mitochondrial numbers. Shmarakov proposes that this accounts partially for the excessive weight gain in the adi-hRBP4 mice.

Gelareh Abulwerdi

Gelareh Abulwerdi is a Ph.D. candidate at the University of Maryland, Baltimore. Follow her on Twitter.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

A new hotspot for cyclooxygenase inhibition
Lipid News

A new hotspot
for cyclooxygenase inhibition

January 21, 2020

Drugs like aspirin dampen inflammation by inhibiting certain enzymes, but can have nasty gastrointestinal side effects so enzymologists are investigating the structure of the enzymes’ active sites in hopes of designing more selective inhibitors.

Your blood type may influence your vulnerability to the winter vomiting virus

Your blood type may influence
your vulnerability to the winter
vomiting virus

January 19, 2020

Norovirus is very infectious, but not everyone is equally vulnerable. Whether you get sick or not may depend on your blood type.

The proteome of the cave bear
Journal News

The proteome of the cave bear

January 18, 2020

If a peptide mass spectrum is like a jigsaw puzzle, then a genome is the picture that researchers use to piece things together. But what do you do when there’s no picture to use as a guide?

Pulse points: 2020

Pulse points: 2020

January 16, 2020

Research can spark change. Here are examples of how scientific inquiry exposes health risks and leads to new treatments for disease.

JLR junior associate editors organize virtual issues
Journal News

JLR junior associate editors organize virtual issues

January 14, 2020

The junior associate editors of the Journal of Lipid Research have organized four virtual issues highlighting cutting-edge research published by the journal.

Taking the measure of glycans
Journal News

Taking the measure of glycans

January 12, 2020

When Lorna De Leoz invited laboratories to participate in her glycomics study, she hoped for 20 responses. Instead, she was deluged by emails from around the world.